These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 10100697

  • 1. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor.
    Salven P, Orpana A, Joensuu H.
    Clin Cancer Res; 1999 Mar; 5(3):487-91. PubMed ID: 10100697
    [Abstract] [Full Text] [Related]

  • 2. Clinical usefulness of serum and plasma vascular endothelial growth factor in cancer patients: which is the optimal specimen?
    Lee JK, Hong YJ, Han CJ, Hwang DY, Hong SI.
    Int J Oncol; 2000 Jul; 17(1):149-52. PubMed ID: 10853032
    [Abstract] [Full Text] [Related]

  • 3. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging?
    George ML, Eccles SA, Tutton MG, Abulafi AM, Swift RI.
    Clin Cancer Res; 2000 Aug; 6(8):3147-52. PubMed ID: 10955796
    [Abstract] [Full Text] [Related]

  • 4. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
    Kraft A, Weindel K, Ochs A, Marth C, Zmija J, Schumacher P, Unger C, Marmé D, Gastl G.
    Cancer; 1999 Jan 01; 85(1):178-87. PubMed ID: 9921991
    [Abstract] [Full Text] [Related]

  • 5. Serum vascular endothelial growth factor is often elevated in disseminated cancer.
    Salven P, Mänpää H, Orpana A, Alitalo K, Joensuu H.
    Clin Cancer Res; 1997 May 01; 3(5):647-51. PubMed ID: 9815732
    [Abstract] [Full Text] [Related]

  • 6. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients.
    Salgado R, Vermeulen PB, Benoy I, Weytjens R, Huget P, Van Marck E, Dirix LY.
    Br J Cancer; 1999 May 01; 80(5-6):892-7. PubMed ID: 10360671
    [Abstract] [Full Text] [Related]

  • 7. Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen.
    Adams J, Carder PJ, Downey S, Forbes MA, MacLennan K, Allgar V, Kaufman S, Hallam S, Bicknell R, Walker JJ, Cairnduff F, Selby PJ, Perren TJ, Lansdown M, Banks RE.
    Cancer Res; 2000 Jun 01; 60(11):2898-905. PubMed ID: 10850435
    [Abstract] [Full Text] [Related]

  • 8. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
    Dosquet C, Coudert MC, Lepage E, Cabane J, Richard F.
    Clin Cancer Res; 1997 Dec 01; 3(12 Pt 1):2451-8. PubMed ID: 9815646
    [Abstract] [Full Text] [Related]

  • 9. Platelet: transporter of vascular endothelial growth factor.
    Verheul HM, Hoekman K, Luykx-de Bakker S, Eekman CA, Folman CC, Broxterman HJ, Pinedo HM.
    Clin Cancer Res; 1997 Dec 01; 3(12 Pt 1):2187-90. PubMed ID: 9815613
    [Abstract] [Full Text] [Related]

  • 10. Determination of vascular endothelial growth factor (VEGF) in circulating blood: significance of VEGF in various leucocytes and platelets.
    Werther K, Christensen IJ, Nielsen HJ.
    Scand J Clin Lab Invest; 2002 Dec 01; 62(5):343-50. PubMed ID: 12387579
    [Abstract] [Full Text] [Related]

  • 11. Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors?
    Tabone MD, Landman-Parker J, Arcil B, Coudert MC, Gerota I, Benbunan M, Leverger G, Dosquet C.
    Clin Cancer Res; 2001 Mar 01; 7(3):538-43. PubMed ID: 11297245
    [Abstract] [Full Text] [Related]

  • 12. Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma.
    Poon RT, Lau CP, Cheung ST, Yu WC, Fan ST.
    Cancer Res; 2003 Jun 15; 63(12):3121-6. PubMed ID: 12810638
    [Abstract] [Full Text] [Related]

  • 13. Serum concentrations of vascular endothelial growth factor in vulvar cancer.
    Hefler L, Tempfer C, Obermair A, Frischmuth K, Sliutz G, Reinthaller A, Leodolter S, Kainz C.
    Clin Cancer Res; 1999 Oct 15; 5(10):2806-9. PubMed ID: 10537345
    [Abstract] [Full Text] [Related]

  • 14. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma.
    Shang ZJ, Li JR, Li ZB.
    Int J Oral Maxillofac Surg; 2002 Oct 15; 31(5):495-8. PubMed ID: 12418564
    [Abstract] [Full Text] [Related]

  • 15. Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with malignant bone tumors.
    Holzer G, Obermair A, Koschat M, Preyer O, Kotz R, Trieb K.
    Med Pediatr Oncol; 2001 Jun 15; 36(6):601-4. PubMed ID: 11344490
    [Abstract] [Full Text] [Related]

  • 16. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
    Robak E, Woźniacka A, Sysa-Jedrzejowska A, Stepień H, Robak T.
    Eur Cytokine Netw; 2001 Jun 15; 12(3):445-52. PubMed ID: 11566625
    [Abstract] [Full Text] [Related]

  • 17. Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1.
    Lissoni P, Malugani F, Bonfanti A, Bucovec R, Secondino S, Brivio F, Ferrari-Bravo A, Ferrante R, Vigoré L, Rovelli F, Mandalà M, Viviani S, Fumagalli L, Gardani GS.
    J Biol Regul Homeost Agents; 2001 Jun 15; 15(2):140-4. PubMed ID: 11501971
    [Abstract] [Full Text] [Related]

  • 18. Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma. The Danish RANX05 Colorectal Cancer Study Group.
    Werther K, Christensen IJ, Brünner N, Nielsen HJ.
    Eur J Surg Oncol; 2000 Nov 15; 26(7):657-62. PubMed ID: 11078612
    [Abstract] [Full Text] [Related]

  • 19. Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancer.
    Feldman AL, Tamarkin L, Paciotti GF, Simpson BW, Linehan WM, Yang JC, Fogler WE, Turner EM, Alexander HR, Libutti SK.
    Clin Cancer Res; 2000 Dec 15; 6(12):4628-34. PubMed ID: 11156212
    [Abstract] [Full Text] [Related]

  • 20. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
    Lip PL, Belgore F, Blann AD, Hope-Ross MW, Gibson JM, Lip GY.
    Invest Ophthalmol Vis Sci; 2000 Jul 15; 41(8):2115-9. PubMed ID: 10892852
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.